Description
An antiviral nucleoside analog; an inhibitor of HIV-1 and hepatitis B reverse transcriptase; inhibits replication of HIV-1 (EC50s = 10-20 nM) and hepatitis B (EC50s = 10-40 nM) in various cell lines; inhibits duck hepatitis B viral DNA synthesis when administered pre- and post-viral inoculation in primary duck hepatocytes; reduces viremia and hepatic WHV replication in a dose-dependent manner in a woodchuck model of chronic WHV infection
Formal name: 4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone
Synonyms: BW 1592|BW 524W91|FTC
Molecular weight: 247.2
CAS: 143491-57-0
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Antivirals|Nucleoside Reverse Transcriptase Inhibitors (NRTIs)||Product Type|Biochemicals|Nucleotides/Nucleosides||Product Type|Biochemicals|Small Molecule Inhibitors|Reverse Transcriptases||Research Area|Immunology & Inflammation||Research Area|Infectious Disease|Viral Diseases|Hepatitis||Research Area|Infectious Disease|Viral Diseases|HIV & AIDS